Compare LPLA & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LPLA | GEHC |
|---|---|---|
| Founded | 1989 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9B | 33.1B |
| IPO Year | 2010 | N/A |
| Metric | LPLA | GEHC |
|---|---|---|
| Price | $376.28 | $83.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $424.55 | $85.89 |
| AVG Volume (30 Days) | 503.1K | ★ 4.3M |
| Earning Date | 01-29-2026 | 10-29-2025 |
| Dividend Yield | ★ 0.33% | 0.17% |
| EPS Growth | N/A | ★ 32.35 |
| EPS | ★ 10.69 | 4.83 |
| Revenue | $15,163,188,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $42.08 | $6.33 |
| Revenue Next Year | $23.63 | $4.38 |
| P/E Ratio | $34.46 | ★ $17.19 |
| Revenue Growth | ★ 34.55 | 3.51 |
| 52 Week Low | $262.83 | $57.65 |
| 52 Week High | $403.58 | $94.80 |
| Indicator | LPLA | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 63.96 | 62.70 |
| Support Level | $354.11 | $82.47 |
| Resistance Level | $373.89 | $85.89 |
| Average True Range (ATR) | 9.39 | 2.33 |
| MACD | 1.38 | 0.68 |
| Stochastic Oscillator | 84.04 | 80.43 |
LPL Financial is the largest US independent broker-dealer, with nearly 29,000 financial advisors affiliated with its platform and roughly 10 million associated customer accounts at the end of 2024. The firm earns the bulk of its profit from interest income earned on client cash balances and from advisory fees and commissions tied to the $1.7 trillion in assets under management or advisory on its platform at year-end 2024. LPL specializes in the provision of turnkey wealth management services for affiliated independent advisors, but maintains a diverse array of affiliation modalities, running the gamut from more traditional employee models to a pure RIA custody approach. It earns tuck-in revenue from recordkeeping fees and the provision of software tools and services to its advisor base.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).